Archives for July 14, 2015

← 2015

CNS drugmaker teams with CDMO on ALS mAb candidate

By Fiona BARRY

CDMO (contract development and manufacturing organisation) Goodwin Biotechnology is working with CNS biotech Q Therapeutics to produce mAbs for a clinical trial to treat motor neuron disease.